Susan Rodriguez Ardelyx, Inc. (ARDX) insider trading activity

Susan Rodriguez is Chief Commercial Officer of ARDELYX, INC.. Currently has a direct ownership of 449,092 shares of ARDX, which is worth approximately $2.12 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 6,703 shares (Common Stock) at a price of $7.81 per share, resulting in proceeds of $52,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 449K

0% 3M change

29.43% 12M change

Total Value Held $2.12 Million

Susan Rodriguez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2024	SELL Open market or private sale	$52,350 $7.81 p/Share	6,703 Reduced 1.47%	449,092 Common Stock
Feb 20 2024	SELL Open market or private sale	$60,620 $8.75 p/Share	6,928 Reduced 1.51%	452,795 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	112,750 Added 19.7%	459,723 Common Stock
Nov 20 2023	SELL Open market or private sale	$20,553 $4.36 p/Share	4,714 Reduced 1.34%	346,973 Common Stock
Aug 21 2023	SELL Open market or private sale	$16,802 $3.55 p/Share	4,733 Reduced 1.34%	348,687 Common Stock
May 23 2023	SELL Open market or private sale	$17,195 $3.65 p/Share	4,711 Reduced 1.32%	353,420 Common Stock
Feb 21 2023	SELL Open market or private sale	$16,758 $3.0 p/Share	5,586 Reduced 1.55%	355,131 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	78,000 Added 17.78%	360,717 Common Stock
Nov 22 2022	SELL Open market or private sale	$6,704 $1.94 p/Share	3,456 Reduced 1.21%	282,717 Common Stock
Aug 22 2022	SELL Open market or private sale	$3,352 $0.98 p/Share	3,420 Reduced 1.18%	286,173 Common Stock
Jun 06 2022	SELL Open market or private sale	$28,548 $0.65 p/Share	43,920 Reduced 13.17%	289,593 Common Stock
May 20 2022	SELL Open market or private sale	$2,295 $0.67 p/Share	3,425 Reduced 1.02%	333,513 Common Stock
Feb 22 2022	SELL Open market or private sale	$2,278 $0.67 p/Share	3,400 Reduced 1.01%	333,938 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	141,000 Added 29.43%	338,031 Common Stock
Nov 22 2021	SELL Open market or private sale	$637 $0.99 p/Share	643 Reduced 0.33%	197,030 Common Stock
Oct 08 2021	BUY Grant, award, or other acquisition	-	150,000 Added 43.14%	197,673 Common Stock
Aug 20 2021	SELL Open market or private sale	$832 $1.32 p/Share	630 Reduced 1.39%	44,673 Common Stock
May 20 2021	SELL Open market or private sale	$4,332 $7.09 p/Share	611 Reduced 1.33%	45,303 Common Stock
Feb 22 2021	SELL Open market or private sale	$4,204 $6.88 p/Share	611 Reduced 1.31%	45,914 Common Stock
Jan 05 2021	BUY Grant, award, or other acquisition	-	32,612 Added 41.21%	46,525 Common Stock

Also insider at

HRTX

HERON THERAPEUTICS, INC. Healthcare

Director

MDRX

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Healthcare

Susan Rodriguez

Chief Commercial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARDX shares.

Notify only if

Value

Insider Trading

Get notified when an Ardelyx, Inc. insider buys or sells ARDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARDELYX, INC.

Track Activities on ARDX

Account